Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Immunobiology. 2009 Oct 31;215(7):535–544. doi: 10.1016/j.imbio.2009.09.006

Figure 6. CRCL activates STAT1, STAT5, AKT and the MAP kinase pathway but impairs the phosphorylation of STAT3 in DC and macrophages.

Figure 6

Day 5 bone marrow derived DC or peritoneal macrophages were incubated for 24 hrs with CRCL (25 μg/ml) or LPS (1 μg/ml) as a positive control. (A) Western blot analysis of total cell extracts was then performed probing for phospho STAT1 (P-STAT1), STAT1, phospho STAT5 (P-STAT5), STAT5, phospho ERK1/2 (P-ERK1/2), ERK1/2, phospho p38 (P-p38), p38, phospho AKT (P-AKT), AKT, phospho STAT3 (P-STAT3), or STAT3.